News
12 May 2026
Frost & Sullivan’s 2026 Global Company of the Year
Frost & Sullivan is pleased to announce that Avance Clinical has been awarded the 2026 Global Company of the Year Recognition in the biotechnology contract research organization (CRO) industry for its outstanding achievements in innovation, strategy execution, and customer impact.
6 September 2022
Avance Clinical announces North American CRO acquisition to expand later phase services for Biotechs
Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the acquisition of CRO partner company C3 Research Associates to enable biotech clients a seamless journey from early phase to later phase studies. Avance Clinical has backing from private equity group Riverside Company for their global expansion program.
9 June 2022
Avance Clinical Announces at BIO 2022: Expansion Across Australia and New Zealand – New Offices and Double Growth
Avance Clinical, the largest premium Australian Contract Research Organization (CRO) for international biotechs, has opened new offices in Sydney and Melbourne, with further expansions planned, and increased clinical staff numbers across the region to support double growth figures.
19 April 2022
Avance Clinical Finalist for Informa Pharma Intelligence Awards 2022 – Best Contract Research Organization in APAC
Avance Clinical, the largest premium Australian Contract Research Organization (CRO) for international biotechs, has been selected as a finalist for the Best Contract Research Organization in APAC by Informa Pharma Intelligence.
31 March 2022
Avance Clinical Announces New Office Opening in Melbourne
Avance Clinical, the Australian CRO for biotechs, has expanded into North America with the acquisition of CRO partner company C3 Research Associates to enable biotech clients a seamless journey from early phase to later phase studies. Avance Clinical has backing from private equity group Riverside Company for their global expansion program.
3 March 2022
Avance Clinical Announces Appointment of Liahna Toy as Head of Business Development
Avance Clinical, the largest full-service Australian Contract Research Organization (CRO) for international biotechs, announced today the appointment of Liahna Toy to the new senior executive role, Head of Business Development.
2 March 2022
Brett Favre Talks Concussion
Listen to football legend Brett Favre on 5AA ‘Rowey’s Sports Show’ talk about concussion in sport and the therapy that leading biotech firm Odyssey Health as in clinical trials with Australia’s CRO Avance Clinical.
14 February 2022
Avance Clinical Announces New Office Opening in Sydney
Avance Clinical, the largest premium Australian Contract Research Organization (CRO) for international biotechs, has opened new offices in Sydney to support its growing clinical team in the greater Sydney region.
25 November 2021
Avance Clinical Featured in Endpoints News on Cell & Gene Therapy Capabilities
The cell and gene therapies (CGT) sector offers unprecedented opportunities for patient disease management across virtually all therapeutic areas.
23 October 2021
Avance Clinical Featured in Fierce Biotech on Intranasal Expertise
With the global intranasal drug delivery market estimated to reach up to $71 billion over the next five years, Avance Clinical is seeing an increase in biotech clinical trials targeting this growing market demand.
10 August 2021
Avance Clinical Awarded Frost & Sullivan 2021 Asia-Pacific CRO Best Practices Award for Customer Value Leadership
Avance Clinical has been awarded the prestigious Frost & Sullivan 2021 Asia-Pacific CRO Customer Value Leadership Award, the second consecutive Asia-Pacific (APAC) CRO Best Practices Award for the company from Frost & Sullivan.
9 July 2021
Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1 Clinical Study Using a Novel Single-Cycle Adenovirus Vaccine Strategy in Australia
The largest Australian full-service CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical today congratulated client Tetherex Pharmaceuticals on first patient dosing for its Phase 1 vaccine clinical trial.
24 June 2021
Avance Clinical Announces Appointment of Asia Biotech Specialist to Support APAC Growth
The leading Australian CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical today announced the appointment of APAC expert Andy Hu as Business Development Manager APAC to support increasing biotech clinical trial demand from the region.
Proven industry
experience & expertise
800+
Studies in the past 10 years
500+
Experienced team members
33k+
Participants past 10 years
30
Years of CRO experience